224 related articles for article (PubMed ID: 20496538)
21. Blockade of tumour necrosis factor-alpha in rheumatoid arthritis: effects on components of rheumatoid cachexia.
Metsios GS; Stavropoulos-Kalinoglou A; Douglas KM; Koutedakis Y; Nevill AM; Panoulas VF; Kita M; Kitas GD
Rheumatology (Oxford); 2007 Dec; 46(12):1824-7. PubMed ID: 18032540
[TBL] [Abstract][Full Text] [Related]
22. [Recent development in research and management of cancer anorexia-cachexia syndrome].
Inui A
Gan To Kagaku Ryoho; 2005 Jun; 32(6):743-9. PubMed ID: 15984510
[TBL] [Abstract][Full Text] [Related]
23. Changes in body mass, energy balance, physical function, and inflammatory state in patients with locally advanced head and neck cancer treated with concurrent chemoradiation after low-dose induction chemotherapy.
Silver HJ; Dietrich MS; Murphy BA
Head Neck; 2007 Oct; 29(10):893-900. PubMed ID: 17405169
[TBL] [Abstract][Full Text] [Related]
24. Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial.
Gordon JN; Trebble TM; Ellis RD; Duncan HD; Johns T; Goggin PM
Gut; 2005 Apr; 54(4):540-5. PubMed ID: 15753541
[TBL] [Abstract][Full Text] [Related]
25. Insulin treatment in cancer cachexia: effects on survival, metabolism, and physical functioning.
Lundholm K; Körner U; Gunnebo L; Sixt-Ammilon P; Fouladiun M; Daneryd P; Bosaeus I
Clin Cancer Res; 2007 May; 13(9):2699-706. PubMed ID: 17473202
[TBL] [Abstract][Full Text] [Related]
26. Evidence that long-term COX-treatment improves energy homeostasis and body composition in cancer patients with progressive cachexia.
Lundholm K; Daneryd P; Körner U; Hyltander A; Bosaeus I
Int J Oncol; 2004 Mar; 24(3):505-12. PubMed ID: 14767534
[TBL] [Abstract][Full Text] [Related]
27. Quality of life and stimulation of weight gain after treatment with megestrol acetate: correlation between cytokine levels and nutritional status, appetite in geriatric patients with wasting syndrome.
Yeh S; Wu SY; Levine DM; Parker TS; Olson JS; Stevens MR; Schuster MW
J Nutr Health Aging; 2000; 4(4):246-51. PubMed ID: 11115810
[TBL] [Abstract][Full Text] [Related]
28. Phase II trial of mirtazapine for cancer-related cachexia and anorexia.
Riechelmann RP; Burman D; Tannock IF; Rodin G; Zimmermann C
Am J Hosp Palliat Care; 2010 Mar; 27(2):106-10. PubMed ID: 19776373
[TBL] [Abstract][Full Text] [Related]
29. Randomized double-blind clinical trial of combined treatment with megestrol acetate plus celecoxib versus megestrol acetate alone in cachexia-anorexia syndrome induced by GI cancers.
Kouchaki B; Janbabai G; Alipour A; Ala S; Borhani S; Salehifar E
Support Care Cancer; 2018 Jul; 26(7):2479-2489. PubMed ID: 29442239
[TBL] [Abstract][Full Text] [Related]
30. Palliative treatment of cancer anorexia with oral suspension of megestrol acetate.
Tomíska M; Tomisková M; Salajka F; Adam Z; Vorlícek J
Neoplasma; 2003; 50(3):227-33. PubMed ID: 12937858
[TBL] [Abstract][Full Text] [Related]
31. Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement.
Barber MD; McMillan DC; Preston T; Ross JA; Fearon KC
Clin Sci (Lond); 2000 Apr; 98(4):389-99. PubMed ID: 10731472
[TBL] [Abstract][Full Text] [Related]
32. [Current views on use of megestrol acetate in oncology practice].
Vyzula R
Vnitr Lek; 1997 Apr; 43(4):250-5. PubMed ID: 9601846
[TBL] [Abstract][Full Text] [Related]
33. The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer.
Barber MD; Ross JA; Voss AC; Tisdale MJ; Fearon KC
Br J Cancer; 1999 Sep; 81(1):80-6. PubMed ID: 10487616
[TBL] [Abstract][Full Text] [Related]
34. Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer.
Gebbia V; Testa A; Gebbia N
Br J Cancer; 1996 Jun; 73(12):1576-80. PubMed ID: 8664133
[TBL] [Abstract][Full Text] [Related]
35. Poor tolerability of thalidomide in end-stage oesophageal cancer.
Wilkes EA; Selby AL; Cole AT; Freeman JG; Rennie MJ; Khan ZH
Eur J Cancer Care (Engl); 2011 Sep; 20(5):593-600. PubMed ID: 21521389
[TBL] [Abstract][Full Text] [Related]
36. Body-composition changes in patients who gain weight while receiving megestrol acetate.
Loprinzi CL; Schaid DJ; Dose AM; Burnham NL; Jensen MD
J Clin Oncol; 1993 Jan; 11(1):152-4. PubMed ID: 8418227
[TBL] [Abstract][Full Text] [Related]
37. [Efficacy evaluation of an oral powder supplement enriched with eicosapentaenoic acid in cancer patients].
Gómez-Candela C; Villarino Sanz M; Horrisberger A; Loria Kohen V; Bermejo LM; Zamora Auñón P
Nutr Hosp; 2011; 26(6):1385-93. PubMed ID: 22411387
[TBL] [Abstract][Full Text] [Related]
38. Eicosapentaenoic acid in cancer improves body composition and modulates metabolism.
Pappalardo G; Almeida A; Ravasco P
Nutrition; 2015 Apr; 31(4):549-55. PubMed ID: 25770317
[TBL] [Abstract][Full Text] [Related]
39. The role of thalidomide and placebo for the treatment of cancer-related anorexia-cachexia symptoms: results of a double-blind placebo-controlled randomized study.
Yennurajalingam S; Willey JS; Palmer JL; Allo J; Del Fabbro E; Cohen EN; Tin S; Reuben JM; Bruera E
J Palliat Med; 2012 Oct; 15(10):1059-64. PubMed ID: 22880820
[TBL] [Abstract][Full Text] [Related]
40. Comparison of three different treatment modalities in the management of cancer cachexia.
Kanat O; Cubukcu E; Avci N; Budak F; Ercan I; Canhoroz M; Olmez F
Tumori; 2013; 99(2):229-33. PubMed ID: 23748819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
